|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
Profile of the Month
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
|
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
Profile of the Month
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
Profile of the Month : September 2008
Jim Wolfgang
Country: Canada Age: 75 Occupation: Retired Union Representative Type of MS: Primary progressive Year of diagnosis: 1976
I have seen many positive changes in the way governments at every level in Canada have responded to people with MS; however, we still have a long way to go.
Read the full article here:
English Espanol Italiano Francais Deutsch Русский
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event
In multiple sclerosis, genes play a role and those related to the inflammatory response may be especially important. The authors of this study found that some specific genes involved in the immune response might be involved in the development of a second relapse of MS.
authors: Corvol JC, Pelletier D, Henry RG, Caillier SJ, Wang J, Pappas D, Casazza S, Okuda DT, Hauser SL, Oksenberg JR, Baranzini SE.
source: Proc Natl Acad Sci U S A. 2008 Aug 8
read more
Will Rogers phenomenon in multiple sclerosis
Changes in the diagnostic criteria have allowed a diagnosis of MS in patients with a single relapse. The authors warn that these patients should not be grouped with patients diagnosed according to the old criteria in clinical trials, because they represent a different group with potentially different characteristics.
authors: Sormani MP, Tintorè M, Rovaris M, Rovira A, Vidal X, Bruzzi P, Filippi M, Montalban X.
source: Ann Neurol. 2008 Aug 7
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
|
|
MS News
 |
 |
| Summaries of MS news from websites around the world. |
Canadian clinical trial research survey
source: University of Victoria, Canada
PhD students at the University of Victoria, Canada, are looking for people to take part in an online survey about how people search for clinical trials data.
read more
|
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|